Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
Go back to Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.29 -1.1 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.39 | 52 Week High | $139.79 | |||
| Open | $288.09 | 52 Week Low | $82.07 | |||
| Day High | $289.98 | P/E | 665.79 | |||
| Day Low | $285.21 | EPS | $0.43 | |||
| Volume | 152,535 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 599,275 | |||||
